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Introduction
The majority of human breast cancers arise from the
transformation of epithelial cells. Numerous oncogenic
events, including gene amplification, loss, and mutation,
have been described that confer a growth-promoting
advantage to breast tumors. A classic example of this is
the identification of HER-2 amplification in a subset of
breast tumors, and the successful use of anti-HER-2
directed therapy in prolonging the survival of patients with
breast tumors that have HER-2 amplification. This example
clearly highlights the importance of understanding the
genetic changes in breast epithelial cells that are
associated with breast cancer progression. However, the
focus on breast epithelial cell transformation has resulted
in the development of several cancer models that ignore
another major regulator of breast cancer progression,
namely the stroma and microenvironment. Several recent
reports from both global gene expression studies and
mouse models indicate that the microenvironment may be
a critical modulator of breast cancer progression. Given
that the microenvironment tends to be more genetically
stable than breast tumor cells, it is possible that breast
cancer therapies aimed at the microenvironment are less
likely to develop acquired resistance. Herein I will briefly
highlight several recent papers that show the importance
of the microenvironment in regulation of breast cancer
progression.
Global gene expression studies
Global gene expression patterns have revealed distinct
subtypes of breast cancer, and can predict metastasis
and survival. The development of gene array technology
has quickly evolved to allow analysis of very small
specimens derived by laser capture microdissection or
cell fractionation. This has given an invaluable view of the
gene expression changes within specific cell types during
breast cancer progression. In this regard, Allinen and
colleagues [1] performed an exhaustive analysis of gene
expression changes using serial analysis of gene
expression (SAGE) on specific cell types (luminal
epithelial, myoepithelial, endothelial, leukocytes, and
myofibroblasts) during breast cancer progression. While
luminal epithelial cells showed gene abnormalities (loss of
heterozygosity) and expression changes during
progression, the most dramatic changes in gene
expression occurred in the myoepithelial cells. This was
despite the fact that the myoepithelial cells showed no
genomic alterations. Interestingly, the gene expression
changes in the myoepithelial cells often included secreted
proteins and receptors, suggesting a paracrine regulation
of breast epithelial cells. To support this, Allinen and
colleagues showed that chemokines that are highly
upregulated in myoepithelial cells (CXCL12 and CXCL14)
can bind breast tumor epithelial cells and regulate their
proliferation, migration and invasion. Inhibition of CXCR4,
the receptor for CXCL12, has been shown to prevent
breast cancer metastasis [2], providing the opportunity for
therapeutic targeting of the microenvironment with
potentially less chance of acquired resistance.
Mouse models
Mammary gland biologists have long believed in the
usefulness of their models for understanding breast
cancer progression, but new, sophisticated genetic and
molecular approaches are really bringing these models to
the forefront.
Integrin receptors transmit signals from the
microenvironment and extracellular matrix to breast
epithelial cells. They have long been implicated in both
normal mammary gland development and tumorigenesis,
and blocking of β1-integrin can reverse the transformed
phenotype of epithelial cells in vitro [3]. White and
colleagues [4] have now used cre/lox recombination
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technology to disrupt β1-integrin expression in the
mammary gland and examined mammary tumorigenesis.
They showed that β1-integrin is required for
transformation of the mammary gland by polyomavirus
middle T oncogene. Importantly, not only was β1-integrin
required for initial transformation of epithelial cells, but
deletion of β1-integrin in tumor cells impaired their
proliferation. This study clearly indicates a role for
extracellular matrix and the microenvironment in regulation
of breast tumor progression, and again highlights a
possible therapeutic target in breast cancer.
Changes in the stroma may modulate breast cancer
progression, and a recent report showed that N-Nitroso-
N-methylurea (NMU)-induced carcinogenesis in the rat
actually acts upon the stroma, rather than the epithelium,
to promote mammary tumorigenesis. Here, Maffini and
colleagues [5] used sophisticated mammary gland
recombination studies to treat either the stroma or the
epithelium with NMU, and found that NMU-treated
epithelial cells formed perfectly normal mammary glands
when implanted into normal untreated stroma. However,
normal mammary epithelial cells implanted into NMU-
treated stroma resulted in mammary tumor formation. This
study clearly challenges the dogma that tumorigenesis
results from accumulating genetic alterations in epithelial
cells. In essence, however, these models all point to the
fact that both genetic changes in epithelial cells and gene
expression changes in the stroma play critical roles in
breast tumor progression.
Conclusions
Global gene expression analysis has challenged several
well accepted models of breast cancer progression. Major
alterations in gene expression occur within the stroma that
surrounds breast tumors and premalignant lesions, and
these changes may better define breast tumor
progression than changes found within the breast tumor
epithelial cells themselves. Supporting this, several
models now exist showing that the microenvironment can
have a profound effect on breast cancer progression. In
addition, recent evidence suggests that gene expression
patterns within primary breast tumors can predict
metastasis and survival, indicating that the potential for a
tumor to metastasize may be encoded in the initial
oncogenic mutations within the tumor. It is possible that
the initial gene expression changes in breast epithelium
may be insufficient on their own to promote breast cancer
metastasis, and that additional changes in the
microenvironment, such as in myoepithelial cells, may
determine the ability of the tumor to invade and
metastasize. This theory is supported by evidence that
myoepithelial cells show tumor suppressor properties [6].
In the end, the competing theories about breast tumor
progression (increasing mutation in epithelial cells or
changes in the microenvironment) and metastasis (gained
during cancer evolution or encoded in the initial oncogenic
mutations) will probably all be combined into an integrated
model of breast cancer progression. New in vitro and in
vivo models that incorporate the role of the
microenvironment in breast cancer progression will serve
to test the hypotheses provided by the gene expression
analysis of breast cancer, and may provide novel targets
for therapeutic intervention.
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